385 related articles for article (PubMed ID: 22298894)
1. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
Parkinson DR; Johnson BE; Sledge GW
Clin Cancer Res; 2012 Feb; 18(3):619-24. PubMed ID: 22298894
[TBL] [Abstract][Full Text] [Related]
2. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
3. Impact of genomics on personalized cancer medicine.
Arteaga CL; Baselga J
Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
[TBL] [Abstract][Full Text] [Related]
4. Targeted medications. New focus on companion tests.
Reinke T
Manag Care; 2012 Feb; 21(2):35-8. PubMed ID: 22393602
[No Abstract] [Full Text] [Related]
5. Era of personalized medicine may herald end of soaring cancer costs.
Keogh B
J Natl Cancer Inst; 2012 Jan; 104(1):12-3, 16-7. PubMed ID: 22173586
[No Abstract] [Full Text] [Related]
6. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
Ludwig WD
Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
[TBL] [Abstract][Full Text] [Related]
7. Getting personal.
Nature; 2011 May; 473(7347):253-4. PubMed ID: 21593815
[No Abstract] [Full Text] [Related]
8. Personalized-medicine trials on the rise.
Benowitz S
J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496
[No Abstract] [Full Text] [Related]
9. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
10. Personalizing oncology: perspectives and prospects.
Mendelsohn J
J Clin Oncol; 2013 May; 31(15):1904-11. PubMed ID: 23589547
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer management: opportunities and barriers to an individualized approach.
Perez EA
Oncologist; 2011; 16 Suppl 1():20-2. PubMed ID: 21278437
[TBL] [Abstract][Full Text] [Related]
12. Cancer biomarkers: current issues and future directions.
Jain KK
Curr Opin Mol Ther; 2007 Dec; 9(6):563-71. PubMed ID: 18041667
[TBL] [Abstract][Full Text] [Related]
13. [Development of biomarkers for molecular target drugs].
Saijo K; Ishioka C
Nihon Rinsho; 2015 Aug; 73(8):1308-12. PubMed ID: 26281683
[TBL] [Abstract][Full Text] [Related]
14. Personalized medicine: the medicine of tomorrow. Foreword.
Tremblay-Servier M
Metabolism; 2013 Jan; 62 Suppl 1():S1. PubMed ID: 23018144
[No Abstract] [Full Text] [Related]
15. Progress towards personalized medicine.
Bates S
Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
[TBL] [Abstract][Full Text] [Related]
16. Bladder cancer: current management and opportunities for a personalized approach.
Galsky MD; Hall SJ
Mt Sinai J Med; 2010; 77(6):587-96. PubMed ID: 21105122
[TBL] [Abstract][Full Text] [Related]
17. Cancer biomarkers, companion diagnostics and personalized oncology.
Ross JS
Biomark Med; 2011 Jun; 5(3):277-9. PubMed ID: 21657836
[No Abstract] [Full Text] [Related]
18. From genomic landscapes to personalized cancer management-is there a roadmap?
Swanton C; Caldas C
Ann N Y Acad Sci; 2010 Oct; 1210():34-44. PubMed ID: 20973797
[TBL] [Abstract][Full Text] [Related]
19. Individualized targeted therapy for glioblastoma: fact or fiction?
Weller M; Stupp R; Hegi M; Wick W
Cancer J; 2012; 18(1):40-4. PubMed ID: 22290256
[TBL] [Abstract][Full Text] [Related]
20. The journey toward personalized cancer therapy.
Tulbah A; Chaudhri N; Al Dayel F; Akhtar M
Adv Anat Pathol; 2014 Jan; 21(1):36-43. PubMed ID: 24316909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
